DELEAGE JEAN

CIK 000119832318 companiesSAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001198323

Recent Transactions

50 trades

Purchase
TALPHERA, INC.$TLPH
Common Stock
2011-02-16$5.00/sh+680,000→ 2,794,907 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+810,129→ 1,821,097 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+279,097→ 2,100,194 total
Sale
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16$5.00/sh−54,875→ 14,713 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+14,713→ 2,114,897 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16+69,588→ 0 total
Other
TALPHERA, INC.$TLPH
Convertible Promissory Notes
2011-02-16
Other
TALPHERA, INC.$TLPH
Warrant to Purchase Series C Convertible Preferred Stock
2011-02-16−40,865→ 69,588 total
Conversion
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−810,129→ 0 total
Conversion
TALPHERA, INC.$TLPH
Series C Convertible Preferred Stock
2011-02-16−14,713→ 0 total
Conversion
TALPHERA, INC.$TLPH
Convertible Promissory Notes
2011-02-16→ 0 total
Conversion
TALPHERA, INC.$TLPH
Series A Convertible Prefered Stock
2011-02-16−500,000→ 0 total
Exercise of In-Money
TALPHERA, INC.$TLPH
Warrant to Purchase Series C Convertible Preferred Stock
2011-02-16−69,588→ 0 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+682,904→ 682,904 total
Conversion
TALPHERA, INC.$TLPH
Series B Convertible Preferred Stock
2011-02-16−218,750→ 0 total
Conversion
TALPHERA, INC.$TLPH
Common Stock
2011-02-16+328,064→ 1,010,968 total
Conversion
Aegerion Pharmaceuticals, Inc.
Senior Subordinated Convertible Promissory Notes
2010-10-27
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$7.60/sh+47,010→ 145,457 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series A Convertible Prefered Stock
2010-10-27−69,176→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+379,545→ 1,465,881 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+1,086,336→ 1,086,336 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+26,771→ 26,771 total
Conversion
Aegerion Pharmaceuticals, Inc.
Senior Subordinated Convertible Promissory Notes
2010-10-27
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+9,353→ 36,124 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2010-10-27−41,768→ 0 total
Purchase
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$9.50/sh+7,128→ 60,502 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series A Convertible Prefered Stock
2010-10-27−2,806,991→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series A Convertible Prefered Stock
2010-10-27−188,514→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2010-10-27−621,923→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$7.60/sh+700,050→ 2,165,931 total
Conversion
Aegerion Pharmaceuticals, Inc.
Series B Convertible Preferred Stock
2010-10-27−15,327→ 0 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$7.60/sh+17,250→ 53,374 total
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+25,490→ 98,447 total
Conversion
Aegerion Pharmaceuticals, Inc.
Senior Subordinated Convertible Promissory Notes
2010-10-27
Conversion
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27+72,957→ 72,957 total
Purchase
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$9.50/sh+289,236→ 2,455,167 total
Purchase
Aegerion Pharmaceuticals, Inc.
Common Stock
2010-10-27$9.50/sh+19,425→ 164,882 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+732,745→ 732,745 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+268,883→ 268,883 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+112,800→ 381,683 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−11,280→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−30,739→ 0 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+4,577,280→ 15,487,876 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30+307,390→ 1,040,135 total
Purchase
Viracta Therapeutics, Inc.$VIRX
Common Stock
2010-06-30$0.28/sh+10,910,596→ 10,910,596 total
Conversion
Viracta Therapeutics, Inc.$VIRX
Series A Preferred Stock
2010-06-30−457,728→ 0 total
Award
RIGEL PHARMACEUTICALS INC$RIGL
Stock Option (Right to Buy)
2010-05-28+15,000→ 15,000 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stocks
2009-12-14$2.01/sh−137,323→ 0 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stocks
2009-12-14$2.01/sh−50,391→ 0 total
Sale
Viracta Therapeutics, Inc.$VIRX
Common Stocks
2009-12-14$2.01/sh−2,044,750→ 0 total

DELEAGE JEAN

Recent Transactions

Companies

Recent Filings

Address